UK markets open in 7 hours 18 minutes

Molecular Partners AG (MOLN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.68+0.41 (+6.58%)
At close: 04:00PM EDT
Show:
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
181,293
9,330
9,344
20,383
10,355
Cost of revenue
-
-
-
-
15,602
Gross profit
-
-
-
-
-5,247
Operating expenses
Research development
54,027
55,718
56,075
43,498
38,203
Selling general and administrative
19,319
16,906
11,027
13,164
9,462
Total operating expenses
73,628
72,749
67,670
57,043
47,765
Operating income or loss
107,665
-63,419
-58,326
-36,660
-37,410
Interest expense
620
548
271
27
-
Total other income/expenses net
-1,319
92
-4,513
-1,110
-218
Income before tax
105,898
-63,783
-62,775
-36,271
-37,036
Income tax expense
2
2
-11
17
0
Income from continuing operations
105,896
-63,785
-62,764
-36,288
-37,036
Net income
105,896
-63,785
-62,764
-36,288
-37,036
Net income available to common shareholders
105,896
-63,785
-62,764
-36,288
-37,036
Basic EPS
-
-2.06
-2.51
-1.69
-1.75
Diluted EPS
-
-2.06
-2.51
-1.69
-1.75
Basic average shares
-
31,005
25,001
21,413
21,168
Diluted average shares
-
31,005
25,001
21,413
21,168
EBITDA
-
-60,670
-59,617
-33,775
-36,486